Following the Symptom Management Cues in CAHPS and HOPE
Join Us Virtually
Event Details
The CAHPS (the Consumer Assessment of Healthcare Providers and Systems) survey and HOPE (Hospice Outcomes and Patient Evaluation) tool are now an integral part of hospice quality assessment. Their focus on common end-of-life symptoms including pain, nausea, dyspnea, anxiety/agitation, bowel function, and sadness can alert the hospice team to areas for assessment and opportunities for optimal symptom management. This presentation focuses on pharmacologic and nonpharmacologic strategies to evaluate, treat, and monitor these symptoms and will discuss ways to effectively communicate with patients and caregivers to maximize both patient comfort and the CAHPS and HOPE assessments.
Objectives:
- Discuss the use of opioids for pain, including dosing considerations, onset of action, and adverse effects
- Understand differences in medications used for nausea and vomiting to help guide use, and review treatment options for constipation and diarrhea
- List pharmacologic and nonpharmacologic treatments for dyspnea, anxiety, agitation, and depression
Dr. Martin earned her Doctor of Pharmacy degree from the University of Nebraska Medical Center and completed an executive residency with the American Society of Consultant Pharmacists. She has enjoyed working in a wide range of nonconventional clinical roles, including pharmacy association management, senior care, pharmacy benefits management, ambulatory care, value-based care, and hospice. She is a board certified geriatric pharmacist, has worked as a North Carolina Clinical Pharmacist Practitioner, and has authored more than a hundred articles for national pharmacy publications. She is a frequent presenter at state and national hospice conferences. Dr. Martin is currently serving in the role of Senior Clinical Manager at Enclara Pharmacia.